BriaCell Therapeutics Corp. - NULL (BCTX)

CUSIP: 107930109

Q3 2023 13F Holders as of 30 Sep 2023

Share change
+1,119,168
SEC-reported price per share
$6.25
Number of holders
18
Value change
+$7,022,784
Number of buys
18

Security key

107930109

Report period

Q3 2023

Institutions

18

Top holders

10

Ownership snapshot

Top reported holders of BCTX - BriaCell Therapeutics Corp. - NULL (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Lynwood Capital Managemen...
Disclosed value leader
Lynwood Capital Managemen...
Comparable rows
0/15
Latest evidence
30 Jun 2023
13F 3/4/5 Highest disclosed value: $10,168,497 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Lynwood Capital Management Inc. has the largest disclosed position value at $10.17M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Lynwood Capital Management Inc.'s linked filing trail.
Disclosed position value Top 5
Lynwood Capital Management Inc. $10.17M
WASATCH ADVISORS LP $3.93M
Redmond Asset Management, LLC $1.07M
ARMISTICE CAPITAL, LLC $937.5K
Jamieson Bondarenko $777.9K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Lynwood Capital Management Inc.
13F
Company
13F
—
denominator unverified
$10,168,497
1,583,878 shares
— 30 Jun 2023
WASATCH ADVISORS LP
13F
Company
13F
—
denominator unverified
$3,929,605
612,088 shares
— 30 Jun 2023
Redmond Asset Management, LLC
13F
Company
13F
—
mixed-class rows
$1,071,463
212,689 shares
mixed-class rows
— 30 Jun 2023
ARMISTICE CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$937,500
375,000 shares
— 30 Jun 2023
Jamieson Bondarenko
3/4/5
Chairman, Director
—
denominator unverified
$777,940
169,856 shares
— 28 Dec 2022
NATIXIS
13F
Company
13F
—
denominator unverified
$579,405
90,250 shares
— 30 Jun 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
18
Shares
1,119,168
Rows available
18
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders
0
Q3 2023 holders
18
Holder diff
18
Investor Q2 2023 Shares Q3 2023 Shares Share Diff Share Chg % Q2 2023 value Q3 2023 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .